Physician profile
Christopher J Schaefer
NPI 1720349558
$5,140.62
in general payments reported to CMS, 2019-2025
19 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,753 · 2020: $1,254 · 2021: $77.02 · 2022: $1,338 · 2023: $348 · 2024: $113 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,624.05 | 2022-2025 | Rosa, Juggerknotless Soft Anchor |
| Ge Healthcare | $1,539.72 | 2019 | |
| Elite Orthopedics, LLC | $1,278.22 | 2020-2021 | |
| Radius Health, INC. | $182.98 | 2022-2025 | Tymlos |
| Depuy Synthes Sales INC. | $113.13 | 2019-2025 | |
| Philips North America LLC | $72.79 | 2019 | |
| Stryker Corporation | $62.89 | 2023-2024 | Inspace, Blueprint Patient Specific Instrumentation |
| Amgen INC. | $50.90 | 2022-2024 | Evenity, Prolia |
| Smith+Nephew, INC. | $46.13 | 2020-2023 | Collagenase Santyl, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Grifols USA, LLC | $24.30 | 2019 | |
| Abbott Laboratories | $20.87 | 2021 | |
| Polynovo North America LLC | $19.14 | 2024 | Novosorb Btm |
| Acumed LLC | $18.40 | 2023 | Innate Implant, Acumed, Inframe Implant |
| Jazz Pharmaceuticals INC. | $16.63 | 2019 | |
| Electromed, INC. | $16.11 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $14.73 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.31 | 2022 | |
| Pfizer INC. | $13.32 | 2019 | |
| Celularity INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.